<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dong C</submitter><funding>Shanghai Committee of Science and Technology</funding><funding>National Natural Science Foundation of China</funding><pagination>1406-1421</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9345618</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(13)</volume><pubmed_abstract>Lung adenocarcinoma (LUAD) is associated with a poor prognosis due to early metastasis to distant organs. TGF-β potently induces epithelial-to-mesenchymal transition (EMT) and promotes invasion and metastasis of cancers. However, the mechanisms underlying this alteration are largely unknown. PTBP3 plays a critical role in RNA splicing and transcriptional regulation. Although accumulating evidence has revealed that PTBP3 exhibits a pro-oncogenic role in several cancers, whether and how PTBP3 mediates TGF-β-induced EMT and metastasis in LUAD remains unknown. The expression levels and prognostic value of PTBP3 were analyzed in human LUAD tissues and matched normal tissues. siRNAs and lentivirus-mediated vectors were used to transfect LUAD cell lines. Various &lt;i>in vitro&lt;/i> experiments including western blot, qRT-PCR, a luciferase reporter assay, chromatin immunoprecipitation (ChIP), transwell migration and invasion assay and in vivo metastasis experiment were performed to determine the roles of PTBP3 in TGF-β-induced EMT and metastasis. PTBP3 expression was significantly upregulated in patients with LUAD, and high expression of PTBP3 indicated a poor prognosis. Intriguingly, we found that PTBP3 expression level in LUAD cell lines was significantly increased by exogenous TGF-β1 in a Smad-dependent manner. Mechanistically, p-Smad3 was recruited to the PTBP3 promoter and activated its transcription. In turn, PTBP3 knockdown abolished TGF-β1-mediated EMT through the inhibition of Smad2/3 expression. Furthermore, PTBP3 overexpression increased lung and liver metastasis of LUAD cells in vivo. PTBP3 is indispensable to TGF-β-induced EMT and metastasis of LUAD cells and is a novel potential therapeutic target for the treatment of LUAD.</pubmed_abstract><journal>Cell cycle (Georgetown, Tex.)</journal><pubmed_title>PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma.</pubmed_title><pmcid>PMC9345618</pmcid><funding_grant_id>No.81974053</funding_grant_id><funding_grant_id>No 18441902300</funding_grant_id><funding_grant_id>16441907800</funding_grant_id><pubmed_authors>Wu K</pubmed_authors><pubmed_authors>Gu S</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Dong C</pubmed_authors><pubmed_authors>Xie S</pubmed_authors></additional><is_claimable>false</is_claimable><name>PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma.</name><description>Lung adenocarcinoma (LUAD) is associated with a poor prognosis due to early metastasis to distant organs. TGF-β potently induces epithelial-to-mesenchymal transition (EMT) and promotes invasion and metastasis of cancers. However, the mechanisms underlying this alteration are largely unknown. PTBP3 plays a critical role in RNA splicing and transcriptional regulation. Although accumulating evidence has revealed that PTBP3 exhibits a pro-oncogenic role in several cancers, whether and how PTBP3 mediates TGF-β-induced EMT and metastasis in LUAD remains unknown. The expression levels and prognostic value of PTBP3 were analyzed in human LUAD tissues and matched normal tissues. siRNAs and lentivirus-mediated vectors were used to transfect LUAD cell lines. Various &lt;i>in vitro&lt;/i> experiments including western blot, qRT-PCR, a luciferase reporter assay, chromatin immunoprecipitation (ChIP), transwell migration and invasion assay and in vivo metastasis experiment were performed to determine the roles of PTBP3 in TGF-β-induced EMT and metastasis. PTBP3 expression was significantly upregulated in patients with LUAD, and high expression of PTBP3 indicated a poor prognosis. Intriguingly, we found that PTBP3 expression level in LUAD cell lines was significantly increased by exogenous TGF-β1 in a Smad-dependent manner. Mechanistically, p-Smad3 was recruited to the PTBP3 promoter and activated its transcription. In turn, PTBP3 knockdown abolished TGF-β1-mediated EMT through the inhibition of Smad2/3 expression. Furthermore, PTBP3 overexpression increased lung and liver metastasis of LUAD cells in vivo. PTBP3 is indispensable to TGF-β-induced EMT and metastasis of LUAD cells and is a novel potential therapeutic target for the treatment of LUAD.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2024-11-15T22:35:34.945Z</modification><creation>2024-11-15T22:35:34.945Z</creation></dates><accession>S-EPMC9345618</accession><cross_references><pubmed>35323096</pubmed><doi>10.1080/15384101.2022.2052530</doi></cross_references></HashMap>